4
Changes in Ownership
ArriVent BioPharma, Inc. Filed Acc 0000902664-24-000903
10% owner bought 555,555 shares at $18.00 ($9,999,990)
- 10% owner acquired 3,929,117 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | 2024-01-30 | Conversion | +3,616,041 | 3,616,041 | I | ||
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | 2024-01-30 | Conversion | +313,076 | 3,929,117 | I | ||
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | 2024-01-30 | Purchase | +555,555 | $18.00 | $9,999,990 | 4,484,672 | I |
| Derivatives | |||||||
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | 2024-01-30 | Conversion · Series A Preferred Stock | −55,000,000 | 0 | I | ||
| HILLHOUSE INVESTMENT MANAGEMENT, LTD. 10% owner | 2024-01-30 | Conversion · Series B Preferred Stock | −4,761,903 | 0 | I | ||
| Open-market purchases · 555,555 sh · avg $18.00 · $9,999,990 | |||||||
Loading xslF345X05/ownership.xml…